KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Cvs Health (CVS) Free Cash Flow (2016 - 2025)

Cvs Health's Free Cash Flow history spans 17 years, with the latest figure at $2.6 billion for Q4 2025.

For the quarter ending Q4 2025, Free Cash Flow rose 138.64% year-over-year to $2.6 billion, compared with a TTM value of $7.8 billion through Dec 2025, up 23.41%, and an annual FY2025 reading of $7.8 billion, up 23.41% over the prior year.
Free Cash Flow for Q4 2025 was $2.6 billion at Cvs Health, up from $98.0 million in the prior quarter.
The five-year high for Free Cash Flow was $8.5 billion in Q3 2022, with the low at -$3.5 billion in Q4 2023.
Average Free Cash Flow over 5 years is $2.7 billion, with a median of $2.6 billion recorded in 2022.
Year-over-year, Free Cash Flow skyrocketed 266.64% in 2021 and then plummeted 177.46% in 2022.
Tracing CVS's Free Cash Flow over 5 years: stood at $3.4 billion in 2021, then plummeted by 177.46% to -$2.6 billion in 2022, then plummeted by 34.36% to -$3.5 billion in 2023, then soared by 130.79% to $1.1 billion in 2024, then soared by 138.64% to $2.6 billion in 2025.
Per Business Quant, the three most recent readings for CVS's Free Cash Flow are $2.6 billion (Q4 2025), $98.0 million (Q3 2025), and $1.3 billion (Q2 2025).